Newark, New Castle, USA, May 11, 2023 (GLOBE NEWSWIRE) -- Growth Plus Reports estimated the global market for in 2022, and it is expected to increase at a revenue CAGR of 3.2% by 2031.

The global market for veterinary euthanasia drugs was analyzed and is expected to rise significantly in terms of revenue share during the forecast period. Veterinary euthanasia is the human termination of an animal's life, usually to save it from pain and suffering. 

Key Takeaways: 

Request a Free Sample PDF: https://www.growthplusreports.com/inquiry/request-sample/veterinary-euthanasia-drugs-market/8881

                                    Veterinary Euthanasia Drugs Market Scope

Report AttributeDetails
CAGR3.2%
Base Year for Estimation2022
Forecast Period2023 to 2031
Historical Year2021
Segments CoveredAnimal Type, Route of Administration, and Region
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Recent Development in the Veterinary Euthanasia Drugs Market: 

Competitive Landscape

A list of the prominent players operating in the global market for veterinary euthanasia drugs includes: 

Market Drivers and Restraints: 

The global veterinary euthanasia drugs market revenue is driven by the rising preference for pet ownership, awareness of animal health, and improved efficacy and efficiency of veterinary drugs. 

However, due to strict regulations governing the use of euthanasia drugs, the availability of alternative methods for animal euthanasia, and ethical concerns associated with euthanasia, the veterinary euthanasia drugs market revenue growth is expected to be restrained. 

Market Segmentation: 

Segmentation By Route of Administration

Based on routes of administration, the injectable euthanasia drugs segment dominates the global veterinary euthanasia drugs market with the largest revenue share. The intravenous route is the most preferred drug administration method in this group. The significant revenue share is attributed to it being the preferable route, causing deep sleep and causing no pain.  

Regional Growth Dynamics

Based on the region, North America, with the largest revenue share, dominates the global veterinary euthanasia drugs market. This large revenue share is because pet adoption rates are rising, as is the prevalence of age-related disorders in pets.

Request for Customization – https://www.growthplusreports.com/inquiry/customization/veterinary-euthanasia-drugs-market/8881

Report Coverage 

Growth Plus Reports analyzed the global market for veterinary euthanasia drugs in-depth. We studied the fundamental market characteristics, significant investment sectors, regional growth analytics, revenue estimates, competing market players, and mergers and acquisitions.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3.  Opportunities
  5. GLOBAL VETERINARY EUTHANASIA DRUGS  MARKET - ANALYSIS & FORECAST, BY ANIMAL TYPE
    1. Companion Animals
      1. Cats
      2. Dogs
      3. Horses
    2. Farm Animals
      1. Cattle
      2. Pigs
      3. Sheep
  6. GLOBAL VETERINARY EUTHANASIA DRUGS MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Injectable Euthanasia Drugs
      1. Intravenous
      2. Intramuscular
      3. Subcutaneous
    2. Inhalant Euthanasia Drugs
    3. Others

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8881

VALUE PROPOSITIONS RELATED TO THE REPORT:

CUSTOMIZATION OPTIONS:

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Birch Allergy Treatment Market by Drug Class (Antihistamines, Cetirizine, Decongestant), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Thyroid Function Test Market by Test (TSH Test, T4 Test), End User (Hospitals, Diagnostic Laboratory) – Global Outlook & Forecast 2023-2031

WHIM Syndrome Market by Treatment (Symptomatic Treatment, Hematopoietic Stem Cell Transplantation), Route of Administration (Oral, Intravenous) – Global Outlook & Forecast 2021-2031

Magnetic Beads Market by Type (Cells & microbe, Nucleic Acid, Proteins, Others), Application (Bioresearch, In-vitro Diagnostics, Others) – Global Outlook & Forecast 2023-2031

Sandhoff Disease Therapeutics Market by Therapy (Gene Therapy, Stem Cell Therapy), Type (Acute Infantile Sandhoff Diseases, Late-Onset Sandhoff Diseases) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.